Ipsen Pharma
Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, neuroscience and rare diseases.
Lobbying Activity
Meeting with Oliver Schenk (Member of the European Parliament)
21 Nov 2024 · Health priorities and rare diseases in the EU
Meeting with Pascal Arimont (Member of the European Parliament)
14 Oct 2024 · Tackling rare diseases in Europe
Meeting with Laurent Castillo (Member of the European Parliament) and
1 Oct 2024 · Europe de la Santé
Meeting with Ondřej Knotek (Member of the European Parliament)
1 Feb 2024 · Pharmaceutical package
Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur) and Teva Pharmaceuticals Europe BV
14 Jul 2022 · Medicines
Meeting with Barry Andrews (Member of the European Parliament)
29 Jun 2022 · Health policy and pharmaceuticals
Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products
6 Jan 2021
Meeting with Vytenis Andriukaitis (Commissioner) and
29 Nov 2017 · Pharmaceutical incentives, antimicrobial resistance